ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 132 filers reported holding ACHILLION PHARMACEUTICALS IN in Q1 2017. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $1,193,000 | -4.1% | 197,794 | -42.7% | 0.00% | – |
| Q3 2019 | $1,244,000 | +40.4% | 345,396 | +4.6% | 0.00% | – |
| Q2 2019 | $886,000 | -37.4% | 330,284 | -30.9% | 0.00% | – |
| Q1 2019 | $1,415,000 | +360.9% | 477,802 | +146.9% | 0.00% | – |
| Q4 2018 | $307,000 | -83.7% | 193,502 | -62.3% | 0.00% | – |
| Q3 2018 | $1,888,000 | +60.1% | 513,147 | +23.1% | 0.00% | – |
| Q2 2018 | $1,179,000 | -12.7% | 416,817 | +14.5% | 0.00% | – |
| Q1 2018 | $1,351,000 | +6.0% | 364,183 | -17.8% | 0.00% | – |
| Q4 2017 | $1,275,000 | -29.8% | 442,778 | +9.4% | 0.00% | – |
| Q3 2017 | $1,817,000 | -26.8% | 404,787 | -25.2% | 0.00% | – |
| Q2 2017 | $2,483,000 | -12.1% | 541,129 | -19.4% | 0.00% | – |
| Q1 2017 | $2,825,000 | +18.2% | 670,974 | +15.9% | 0.00% | – |
| Q4 2016 | $2,391,000 | -42.7% | 578,923 | +12.4% | 0.00% | -100.0% |
| Q3 2016 | $4,170,000 | +6.8% | 514,851 | +2.9% | 0.00% | 0.0% |
| Q2 2016 | $3,903,000 | +1.9% | 500,417 | +0.8% | 0.00% | 0.0% |
| Q1 2016 | $3,831,000 | -40.6% | 496,298 | -16.9% | 0.00% | -50.0% |
| Q4 2015 | $6,447,000 | +5.0% | 597,536 | -32.7% | 0.00% | 0.0% |
| Q3 2015 | $6,139,000 | -27.5% | 888,485 | -7.1% | 0.00% | -33.3% |
| Q2 2015 | $8,472,000 | +47.7% | 956,105 | +64.4% | 0.00% | +50.0% |
| Q1 2015 | $5,735,000 | +11.7% | 581,645 | +38.8% | 0.00% | +100.0% |
| Q4 2014 | $5,134,000 | -6.5% | 419,060 | -23.8% | 0.00% | -50.0% |
| Q3 2014 | $5,489,000 | +531.6% | 550,121 | +378.9% | 0.00% | – |
| Q2 2014 | $869,000 | +1509.3% | 114,882 | +589.3% | 0.00% | – |
| Q1 2014 | $54,000 | -89.2% | 16,666 | -88.9% | 0.00% | – |
| Q4 2013 | $498,000 | -79.9% | 149,918 | -81.7% | 0.00% | -100.0% |
| Q3 2013 | $2,480,000 | -38.6% | 821,190 | +66.5% | 0.00% | -50.0% |
| Q2 2013 | $4,036,000 | – | 493,324 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 13,633,220 | $56,305,000 | 7.98% |
| BVF INC/IL | 2,423,300 | $10,008,000 | 2.01% |
| EMORY UNIVERSITY | 454,102 | $1,875,000 | 1.85% |
| DAFNA Capital Management LLC | 196,500 | $812,000 | 0.71% |
| Orbimed Advisors | 13,107,200 | $54,133,000 | 0.69% |
| RTW INVESTMENTS, LP | 286,285 | $1,182,000 | 0.44% |
| Marcus Capital, LLC | 100,000 | $413,000 | 0.44% |
| Rock Springs Capital Management LP | 1,375,000 | $5,679,000 | 0.38% |
| Spark Investment Management LLC | 978,600 | $4,041,000 | 0.33% |
| Bellevue Group AG | 240,000 | $991,000 | 0.20% |